Microbix Biosystems Inc.

MISSISSAUGA, A6 · Medtech · Public

Infectious disease diagnostic solutions and vial filling equipment for diagnostics manufacturing

Claim this profile

Follows are private to you and power your alerts

Updated · microbix.com

Sector
Medtech
Headquarters
MISSISSAUGA, A6
Latest Form D
$43K offered, Jul 2021
Total capital
$699K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$699K
5 Form D · last Jul 2021
63 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
2 pending · first 2019
Rank in peer group#45 of 160

Capital timeline

2009201120132015201720192021FEDERAL ↑EQUITY ↓Cumulative $742K3rd Form D$239K4th Form D$75K
2009201320172021FEDERAL ↑EQUITY ↓Cumulative $742K3rd Form D$239K

Latest events

  • Offering registeredForm D · SEC · 5th filing$43K
  • Private capital raisedForm D · SEC · 4th filing$75K
  • Private capital raisedForm D · SEC · 3rd filing$239K
  • Private capital raisedForm D · SEC · 2nd filing$296K
  • Private capital raisedForm D · SEC · 1st filing$88K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#45 · top 28%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Andrew C PollockDirectorNamed in SEC Form D filings
  • Anthony GiovinazzoDirectorNamed in SEC Form D filings
  • Cameron GroomeExecutive Officer, DirectorNamed in SEC Form D filings
  • James A LongExecutive OfficerNamed in SEC Form D filings
  • Jim CurrieExecutive OfficerNamed in SEC Form D filings
  • Joseph D RennerDirectorNamed in SEC Form D filings
Show all 12 people
  • Mark A CochranDirectorNamed in SEC Form D filings
  • Martin MarinoDirectorNamed in SEC Form D filings
  • PETER BLECHERDirectorNamed in SEC Form D filings
  • Philip A CasselliExecutive OfficerNamed in SEC Form D filings
  • Vaughn C Embro-PantalonyDirectorNamed in SEC Form D filings
  • William J GastleExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 4
Show all 4 patent records
  • AIRXPANDERS INCSimilar federal contract value in Medtech · null in contracts
  • Mantara IncSimilar federal contract value in Medtech · null in contracts
  • SciLogica CorpSimilar federal contract value in Medtech · null in contracts
  • VERAX BIOMEDICAL INCSimilar federal contract value in Medtech · null in contracts
  • CardioFocus, Inc.Similar federal contract value in Medtech · null in contracts
  • DIOPSYS INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .